HMGB1 released by activated platelets, activated leukocytes, and necrotic cells influences leukocyte functions, favoring neoangiogenesis (197), a tumor-permissive environment in experimental models (198, 199) and—possibly via NET induction—favoring a prothrombotic state in tumor-bearing patients (135). Here, HMGB1 is linked to neoplasm.